185 related articles for article (PubMed ID: 25870973)
1. Therapeutic interventions using a combination of Telmisartan and omega 3-fatty acids in sodium arsenite-induced vascular endothelial dysfunction in rats: modulation through ATP-sensitive K+ channels and eNOS.
Nirwane A; Pawar V; Majumdar A
J Complement Integr Med; 2015 Jun; 12(2):143-51. PubMed ID: 25870973
[TBL] [Abstract][Full Text] [Related]
2. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
Kaur T; Goel RK; Balakumar P
Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
[TBL] [Abstract][Full Text] [Related]
3. The defensive effect of benfotiamine in sodium arsenite-induced experimental vascular endothelial dysfunction.
Verma S; Reddy K; Balakumar P
Biol Trace Elem Res; 2010 Oct; 137(1):96-109. PubMed ID: 19943121
[TBL] [Abstract][Full Text] [Related]
4. Effect of bis (maltolato) oxovanadium (BMOV) in uric acid and sodium arsenite-induced vascular endothelial dysfunction in rats.
Jindal S; Singh M; Balakumar P
Int J Cardiol; 2008 Aug; 128(3):383-91. PubMed ID: 17658639
[TBL] [Abstract][Full Text] [Related]
5. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
Jyoti U; Kansal SK; Kumar P; Goyal S
Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
[TBL] [Abstract][Full Text] [Related]
6. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
Kaur J; Reddy K; Balakumar P
Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
[TBL] [Abstract][Full Text] [Related]
7. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
Chakkarwar VA
Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
[TBL] [Abstract][Full Text] [Related]
8. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
Shah DI; Singh M
Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
[TBL] [Abstract][Full Text] [Related]
10. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
Balakumar P; Sharma R; Singh M
Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
[TBL] [Abstract][Full Text] [Related]
11. Fish oil blunted nicotine-induced vascular endothelial abnormalities possibly via activation of PPARγ-eNOS-NO signals.
Taneja G; Mahadevan N; Balakumar P
Cardiovasc Toxicol; 2013 Jun; 13(2):110-22. PubMed ID: 23208382
[TBL] [Abstract][Full Text] [Related]
12. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome.
Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K
Can J Physiol Pharmacol; 2011 May; 89(5):355-64. PubMed ID: 21619437
[TBL] [Abstract][Full Text] [Related]
13. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery.
White R; Hiley CR
Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801
[TBL] [Abstract][Full Text] [Related]
14. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
Kathuria S; Mahadevan N; Balakumar P
Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
[TBL] [Abstract][Full Text] [Related]
15. Treatment with n-3 polyunsaturated fatty acids reverses endothelial dysfunction and oxidative stress in experimental menopause.
Gortan Cappellari G; Losurdo P; Mazzucco S; Panizon E; Jevnicar M; Macaluso L; Fabris B; Barazzoni R; Biolo G; Carretta R; Zanetti M
J Nutr Biochem; 2013 Jan; 24(1):371-9. PubMed ID: 23159066
[TBL] [Abstract][Full Text] [Related]
16. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
Dhar I; Dhar A; Wu L; Desai K
J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
[TBL] [Abstract][Full Text] [Related]
17. Activation of protein kinase A improves vascular endothelial dysfunction.
Shah DI; Singh M
Endothelium; 2006; 13(4):267-77. PubMed ID: 16990183
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
19. Persistence of EDHF pathway and impairment of the nitric oxide pathway after chronic mercury chloride exposure in rats: mechanisms of endothelial dysfunction.
Omanwar S; Ravi K; Fahim M
Hum Exp Toxicol; 2011 Nov; 30(11):1777-84. PubMed ID: 21148200
[TBL] [Abstract][Full Text] [Related]
20. Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus.
Schäfer A; Flierl U; Vogt C; Menninger S; Tas P; Ertl G; Bauersachs J
Pharmacol Res; 2007 Sep; 56(3):217-23. PubMed ID: 17669665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
